Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Activation of angiotensin type 2 (AT2) receptors prevents myocardial hypertrophy in Zucker diabetic fatty rats.

Castoldi G, di Gioia CRT, Roma F, Carletti R, Manzoni G, Stella A, Zerbini G, Perseghin G.

Acta Diabetol. 2019 Jan;56(1):97-104. doi: 10.1007/s00592-018-1220-1. Epub 2018 Sep 5.

PMID:
30187136
2.

Prevention of diabetic nephropathy by compound 21, selective agonist of angiotensin type 2 receptors, in Zucker diabetic fatty rats.

Castoldi G, di Gioia CR, Bombardi C, Maestroni S, Carletti R, Steckelings UM, Dahlöf B, Unger T, Zerbini G, Stella A.

Am J Physiol Renal Physiol. 2014 Nov 15;307(10):F1123-31. doi: 10.1152/ajprenal.00247.2014. Epub 2014 Sep 3.

3.

Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats.

Rehman A, Leibowitz A, Yamamoto N, Rautureau Y, Paradis P, Schiffrin EL.

Hypertension. 2012 Feb;59(2):291-9. doi: 10.1161/HYPERTENSIONAHA.111.180158. Epub 2011 Dec 19.

PMID:
22184324
4.

Oral treatment with a zinc complex of acetylsalicylic acid prevents diabetic cardiomyopathy in a rat model of type-2 diabetes: activation of the Akt pathway.

Korkmaz-Icöz S, Al Said S, Radovits T, Li S, Brune M, Hegedűs P, Atmanli A, Ruppert M, Brlecic P, Lehmann LH, Lahrmann B, Grabe N, Yoshikawa Y, Yasui H, Most P, Karck M, Szabó G.

Cardiovasc Diabetol. 2016 May 6;15:75. doi: 10.1186/s12933-016-0383-8.

5.

Possible synergistic effect of direct angiotensin II type 2 receptor stimulation by compound 21 with memantine on prevention of cognitive decline in type 2 diabetic mice.

Iwanami J, Mogi M, Tsukuda K, Jing F, Ohshima K, Wang XL, Nakaoka H, Kan-no H, Chisaka T, Bai HY, Min LJ, Horiuchi M.

Eur J Pharmacol. 2014 Feb 5;724:9-15. doi: 10.1016/j.ejphar.2013.12.015. Epub 2013 Dec 18.

PMID:
24361310
6.

Chronic NF-κB blockade improves renal angiotensin II type 1 receptor functions and reduces blood pressure in Zucker diabetic rats.

Luo H, Wang X, Wang J, Chen C, Wang N, Xu Z, Chen S, Zeng C.

Cardiovasc Diabetol. 2015 Jun 10;14:76. doi: 10.1186/s12933-015-0239-7.

7.

Taurine may prevent diabetic rats from developing cardiomyopathy also by downregulating angiotensin II type2 receptor expression.

Li C, Cao L, Zeng Q, Liu X, Zhang Y, Dai T, Hu D, Huang K, Wang Y, Wang X, Li D, Chen Z, Zhang J, Li Y, Sharma R.

Cardiovasc Drugs Ther. 2005 Mar;19(2):105-12.

PMID:
16025228
8.

The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis.

Chow BS, Koulis C, Krishnaswamy P, Steckelings UM, Unger T, Cooper ME, Jandeleit-Dahm KA, Allen TJ.

Diabetologia. 2016 Aug;59(8):1778-90. doi: 10.1007/s00125-016-3977-5. Epub 2016 May 11.

PMID:
27168137
9.

Salacia oblonga root decreases cardiac hypertrophy in Zucker diabetic fatty rats: inhibition of cardiac expression of angiotensin II type 1 receptor.

Huang TH, He L, Qin Q, Yang Q, Peng G, Harada M, Qi Y, Yamahara J, Roufogalis BD, Li Y.

Diabetes Obes Metab. 2008 Jul;10(7):574-85. Epub 2007 Jul 21.

PMID:
17645561
10.

Treatment of cardiovascular dysfunction associated with the metabolic syndrome and type 2 diabetes.

Oltman CL, Kleinschmidt TL, Davidson EP, Coppey LJ, Lund DD, Yorek MA.

Vascul Pharmacol. 2008 Jan;48(1):47-53. doi: 10.1016/j.vph.2007.11.005. Epub 2007 Nov 29.

PMID:
18164667
11.
12.

Angiotensin AT2 receptor agonist prevents salt-sensitive hypertension in obese Zucker rats.

Ali Q, Patel S, Hussain T.

Am J Physiol Renal Physiol. 2015 Jun 15;308(12):F1379-85. doi: 10.1152/ajprenal.00002.2015. Epub 2015 Apr 8.

13.

Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes.

Ramírez E, Klett-Mingo M, Ares-Carrasco S, Picatoste B, Ferrarini A, Rupérez FJ, Caro-Vadillo A, Barbas C, Egido J, Tuñón J, Lorenzo Ó.

Cardiovasc Diabetol. 2013 Nov 21;12:172. doi: 10.1186/1475-2840-12-172.

15.
16.

Activation of retinoid receptor-mediated signaling ameliorates diabetes-induced cardiac dysfunction in Zucker diabetic rats.

Guleria RS, Singh AB, Nizamutdinova IT, Souslova T, Mohammad AA, Kendall JA Jr, Baker KM, Pan J.

J Mol Cell Cardiol. 2013 Apr;57:106-18. doi: 10.1016/j.yjmcc.2013.01.017. Epub 2013 Feb 5.

17.

Impaired responsiveness of renal sensory nerves in streptozotocin-treated rats and obese Zucker diabetic fatty rats: role of angiotensin.

Kopp UC, Cicha MZ, Yorek MA.

Am J Physiol Regul Integr Comp Physiol. 2008 Mar;294(3):R858-66. doi: 10.1152/ajpregu.00830.2007. Epub 2008 Jan 16.

18.
19.

Eplerenone prevents salt-induced vascular stiffness in Zucker diabetic fatty rats: a preliminary report.

Resch M, Schmid P, Amann K, Fredersdorf S, Weil J, Schach C, Birner C, Griese DP, Kreuzer P, Brunner S, Luchner A, Riegger GA, Endemann DH.

Cardiovasc Diabetol. 2011 Oct 18;10:94. doi: 10.1186/1475-2840-10-94.

20.

Long-term severe diabetes only leads to mild cardiac diastolic dysfunction in Zucker diabetic fatty rats.

Daniels A, Linz D, van Bilsen M, Rütten H, Sadowski T, Ruf S, Juretschke HP, Neumann-Haefelin C, Munts C, van der Vusse GJ, van Nieuwenhoven FA.

Eur J Heart Fail. 2012 Feb;14(2):193-201. doi: 10.1093/eurjhf/hfr166.

Supplemental Content

Support Center